Please Wait
Applying Filters...
menu
    • menu
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Edotreotide

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ITM: Phase 3 COMPETE QoL Data for Lu-edotreotide at ASCO
    ITM: Phase 3 COMPETE QoL Data for Lu-edotreotide at ASCO

    30 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/30/3303892/0/en/itm-announces-phase-3-compete-patient-reported-quality-of-life-data-with-n-c-a-lu-edotreotide-itm-11-vs-everolimus-at-asco-2026.html

    GLOBENEWSWIRE
    30 May 2026
    Share Share
    ITM to Present COMPETE Phase 3 Dosimetry Data at SNMMI 2026
    ITM to Present COMPETE Phase 3 Dosimetry Data at SNMMI 2026

    19 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/19/3297440/0/en/itm-to-announce-dosimetry-data-from-the-phase-3-compete-trial-at-snmmi-2026-and-host-satellite-symposium.html

    GLOBENEWSWIRE
    19 May 2026
    Share Share
    ITM Announces COMPETE Analyses for ITM-11 in pNETs at ENETS 2026
    ITM Announces COMPETE Analyses for ITM-11 in pNETs at ENETS 2026

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3249959/0/en/ITM-Announces-Phase-3-COMPETE-Trial-Post-Hoc-Subgroup-Analyses-with-n-c-a-Lu-edotreotide-ITM-11-in-Patients-with-Pancreatic-Neuroendocrine-Tumors-at-ENETS-2026-Conference.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    ITM Announces FDA Acceptance of NDA & PDUFA Date for ITM-11
    ITM Announces FDA Acceptance of NDA & PDUFA Date for ITM-11

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187074/0/en/ITM-Announces-FDA-Acceptance-of-New-Drug-Application-NDA-and-PDUFA-Date-for-n-c-a-177Lu-edotreotide-ITM-11-in-Gastroenteropancreatic-Neuroendocrine-Tumors-GEP-NETs.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    ITM Reveals Higher Response Rates Of (ITM-11) Vs. Everolimus
    ITM Reveals Higher Response Rates Of (ITM-11) Vs. Everolimus

    25 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/25/3174139/0/en/ITM-Announces-Analyses-from-Phase-3-COMPETE-Data-Showing-Higher-Objective-Response-Rates-with-n-c-a-177Lu-edotreotide-ITM-11-vs-Everolimus-Across-Subgroups-of-Patients-with-GEP-NET.html

    GLOBENEWSWIRE
    25 Oct 2025
    Share Share
    ITM’s Ph3 COMPETE Shows Higher ORR for ITM-11 vs Everolimus
    ITM’s Ph3 COMPETE Shows Higher ORR for ITM-11 vs Everolimus

    18 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/18/3168949/0/en/ITM-Announces-Phase-3-COMPETE-Data-Demonstrating-a-Statistically-Significant-Higher-Objective-Response-Rate-with-n-c-a-177Lu-edotreotide-ITM-11-vs-Everolimus-in-Patients-with-Gastr.html

    GLOBENEWSWIRE
    18 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.